Ever-Growing USA on MSN15h
Big Pharma’s Worst Nightmare or a Total Ripoff? The Truth About Hims’ Cheap Weight Loss Plans
Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...
BioPharma Dive18h
Axsome secures top drug’s future with Teva patent settlement
Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy of Auvelity from entering the U.S. market until at least 2038.
manilatimes23h
Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr - bupropion HCl) Patent Litigation
The settlement agreement resolves all outstanding patent litigation relating to AUVELITY.